‘Hands Off Our NHS’: Anti-Palantir Protests Break Out in UK Over Deal With National Health Service

Why It Matters

The clash underscores mounting scrutiny of foreign AI vendors handling sensitive health data, potentially reshaping UK public‑sector procurement and reinforcing data‑sovereignty safeguards.

Key Takeaways

• Around 80 protesters demanded Palantir’s removal from NHS contract
• NHS‑Palantir deal valued up to $440 million, runs through 2031 with break clause
• MPs’ report labels Palantir reliance as “unacceptable point of weakness.”
• Government review may trigger contract termination before February break clause
• Critics fear data breaches and loss of public trust in health services

Pulse Analysis

Palantir’s partnership with the UK National Health Service began in the early days of the Covid‑19 pandemic, when the government sought rapid data‑analytics capabilities to track infections. Since then, the firm has secured a series of public‑sector contracts, culminating in a federated data platform intended to streamline patient pathways and cut operating‑theatre waste. While the company touts efficiency gains, the NHS’s fragmented adoption—most notably Greater Manchester’s refusal to use the platform—has sparked debate over the true value of outsourcing critical health‑data infrastructure to an offshore provider.

The Manchester protest on June 11 amplified those concerns, drawing roughly 80 activists who framed the issue as both a privacy and a political battle. Demonstrators cited Palantir’s work with U.S. Immigration and Customs Enforcement and the Israeli military, arguing that a foreign‑owned AI vendor could jeopardize national security and contravene UK values. The involvement of groups like Pull the Plug, Amnesty International, and the health‑care union Unison signals a broader civil‑society pushback against what they perceive as unchecked AI deployment in public services.

Legislative scrutiny is now intensifying. A parliamentary report labeled the NHS‑Palantir relationship an “unacceptable point of weakness,” prompting Technology Secretary Liz Kendall to order a comprehensive review before the contract’s February break clause. The outcome could set a precedent for future AI procurements, forcing the UK to balance innovation speed with data sovereignty and public trust. If the contract is terminated, it may open the market to domestic vendors and reshape the regulatory landscape governing AI use in health care, while a continuation could cement Palantir’s foothold in the British public sector.